Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check7 days agoChange DetectedThe Conditions section no longer lists Schizophrenia or the related MedlinePlus Genetics topic.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check22 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedThe page now includes topic tags for Schizophrenia and related resources (MedlinePlus Genetics) and shows a Revision: v3.4.2. The prior funding notice about government operating status and the earlier Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check57 days agoChange DetectedAdded a government-funding notice about potential delays and status of NIH facilities, and a site revision tag (Revision: v3.4.1). Removed the related topics 'Schizophrenia' and 'MedlinePlus Genetics' as well as the previous revision tag 'Revision: v3.4.0' from the page.SummaryDifference0.4%

- Check64 days agoChange DetectedAdded a Show glossary option and updated metadata labels, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.